Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 3Phase NA 2Phase EARLY_PHASE1 2Phase 3 2Phase 2/3 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3Genitourinary 3Gastrointestinal 3Breast 3Sarcoma 1Other solid neoplasm 1Gynecologic 1

Conditions

Prostatic Neoplasms 3Urinary Bladder Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 93Nivolumab 61Docetaxel 55Cyclophosphamide 49enzalutamide 44Magnetic Resonance Spectroscopy 33Ipilimumab 33Gemcitabine 32Abiraterone Acetate 30Prednisone 29fludarabine 28Everolimus 27Paclitaxel 25Cisplatin 24Radiotherapy 23Carboplatin 23Sunitinib 22cabozantinib 21atezolizumab 20Radiosurgery 20Specimen Handling 19Sorafenib 18Bevacizumab 18pazopanib 17bicalutamide 17abiraterone 17Biopsy 15temsirolimus 14darolutamide 14apalutamide 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Positron-Emission Tomography × Genitourinary × Clear all
NCT02809690 2023-09-07

18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer

University of Southern California

Phase 1 Terminated
18 enrolled
Genitourinary

Prostatic Neoplasms

NCT02297386 2018-08-06

[18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
3 enrolled
Genitourinary

Prostatic Neoplasms

NCT02437539 2015-08-24

uPAR-PET

Rigshospitalet, Denmark

Phase 1 Completed
10 enrolled
BreastGenitourinary

Urinary Bladder Neoplasms, Breast Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡